Venture Central News & Media
Medical device company Contraline became the first to implant a hydrogel-based male contraceptive into humans in a clinical trial. The Charlottesville, Virginia company was founded in 2015.
The University of Virginia announced plans to launch a biotechnology institute that positions UVA at the very forefront of cutting-edge medicine.
Venture Central is committed to diversity, equity, and inclusion in the entrepreneurial ecosystem.
Nationally, women founders received less than 3 percent of startup funding in 2020. As of 2021, Black founders received 1.2 percent of startup funding.
We recognize the systemic and structural issues affecting women and people of color in the entrepreneurial ecosystem. We take a proactive approach to engage women and historically underrepresented founders and entrepreneurial ecosystem supporters.